| Pharmacological intervention to modulate HDL: what do we target? NJ Woudberg, S Pedretti, S Lecour, R Schulz, N Vuilleumier, RW James, ... Frontiers in pharmacology 8, 989, 2018 | 81 | 2018 |
| Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury MC Brulhart-Meynet, V Braunersreuther, J Brinck, F Montecucco, JC Prost, ... PloS one 10 (3), e0119664, 2015 | 53 | 2015 |
| HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity MA Frias, S Pedretti, D Hacking, S Somers, L Lacerda, LH Opie, ... Atherosclerosis 228 (1), 110-116, 2013 | 52 | 2013 |
| High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection: role of STAT3 as part of the SAFE pathway MA Frias, S Lecour, RW James, S Pedretti Jak-Stat 1 (2), 92-100, 2012 | 44 | 2012 |
| STAT3α interacts with nuclear GSK3beta and cytoplasmic RISK pathway and stabilizes rhythm in the anoxic-reoxygenated embryonic heart S Pedretti, E Raddatz Basic research in cardiology 106, 355-369, 2011 | 34 | 2011 |
| HDL protects against myocardial ischemia reperfusion injury via miR-34b and miR-337 expression which requires STAT3 S Pedretti, MC Brulhart-Meynet, F Montecucco, S Lecour, RW James, ... PLoS One 14 (6), e0218432, 2019 | 25 | 2019 |
| Cardiac preconditioning with sphingosine-1-phosphate requires activation of signal transducer and activator of transcription-3: cardiovascular topic RF Kelly-Laubscher, JC King, D Hacking, S Somers, S Hastie, T Stewart, ... Cardiovascular journal of Africa 25 (3), 118-123, 2014 | 23 | 2014 |
| Specific inhibition of HCN channels slows rhythm differently in atria, ventricle and outflow tract and stabilizes conduction in the anoxic-reoxygenated embryonic heart model A Sarre, S Pedretti, S Gardier, E Raddatz Pharmacological research 61 (1), 85-91, 2010 | 18 | 2010 |
| Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics A Copaescu, P Choshi, S Pedretti, E Mouhtouris, J Peter, JA Trubiano Frontiers in pharmacology 12, 640012, 2021 | 16 | 2021 |
| Adenosine A1 receptor activation is arrhythmogenic in the developing heart through NADPH oxidase/ERK-and PLC/PKC-dependent mechanisms E Robin, J Sabourin, R Benoit, S Pedretti, E Raddatz Journal of molecular and cellular cardiology 51 (6), 945-954, 2011 | 16 | 2011 |
| HIV-associated immune dysregulation in the skin: a crucible for exaggerated inflammation and hypersensitivity T Chimbetete, C Buck, P Choshi, R Selim, S Pedretti, SJ Divito, EJ Phillips, ... Journal of Investigative Dermatology 143 (3), 362-373, 2023 | 11 | 2023 |
| IFN-γ ELISpot in severe cutaneous adverse reactions to first-line Antituberculosis drugs in an HIV endemic setting M Porter, P Choshi, S Pedretti, T Chimbetete, R Smith, G Meintjes, ... Journal of Investigative Dermatology 142 (11), 2920-2928. e5, 2022 | 8 | 2022 |
| Transient anoxia and oxyradicals induce a region-specific activation of MAPKs in the embryonic heart S Gardier, S Pedretti, A Sarre, E Raddatz Molecular and cellular biochemistry 340, 239-247, 2010 | 8 | 2010 |
| Rooibos herbal tea reduces allergic basophil activation in adult atopic patients S Pedretti, J Peter Journal of ethnopharmacology 252, 112353, 2020 | 7 | 2020 |
| An overview of receptors and granular contents of mast cells and basophils as they pertain to allergy diagnosis S Pedretti, JG Peter Current Allergy & Clinical Immunology 31 (3), 156-161, 2018 | 2 | 2018 |
| Skin infiltrating T-cell profile of drug reaction with eosinophilia and systemic symptoms (DRESS) reactions among HIV-infected patients T Chimbetete, P Choshi, S Pedretti, M Porter, R Roberts, R Lehloenya, ... Frontiers in Medicine 10, 1118527, 2023 | 1 | 2023 |
| P652 The cardioprotective effect of exogenous sphingosine-1-phosphate requires the activation of endogenous sphingosine-1-phosphate via the sphingosine kinase 1. S Pedretti, MA Frias, RW James, S Lecour Cardiovascular Research 103, 2014 | 1 | 2014 |
| Early Use Of Intravenous Methylprednisolone Attenuates Positive Challenge Reactions During Sequential Additive Drug Challenge B Thwala, N Teixeira, A Mpungose, M Porter, S Pedretti, R Selim, A Zulu, ... Journal of Allergy and Clinical Immunology 153 (2), AB169, 2024 | | 2024 |
| PA-631 The immunopathogenic mechanisms of severe cutaneous adverse drug reactions to first line anti-tuberculosis drugs P Chosi, S Pedretti, R Lehloenya, E Phillips, J Peter BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
| Multiomic single-cell sequencing defines tissue-specific responses in Stevens-Johnson Syndrome and Toxic epidermal necrolysis A Gibson, R Ram, R Gangula, Y Li, E Mukherjee, AM Palubinsky, ... bioRxiv, 2023 | | 2023 |
Sandrine LecourProfessor, University of Cape Town在 uct.ac.za 的电子邮件经过验证
